Ingrown toenail monograph
This article was originally published in The Tan Sheet
Executive Summary
Sodium sulfide 1% gel is safe, effective for OTC use in treating pain and discomfort associated with ingrown toenails, according to final rule published in 1May 7 Federal Register. Rule creates a new monograph for OTC ingrown toenail relief products in which sodium sulfide 1% is the first ingredient. FDA stipulates gel be used with a retainer ring system to keep product at the area of application, as suggested in the agency's October 2002 proposed rule (2"The Tan Sheet" Oct. 7, 2002, p. 14). Schering-Plough submitted data on the safety of the retainer ring in October 1998; the firm has said in the past it plans to market a sodium sulfide product under its Dr. Scholl's foot care brand. Schering may introduce a product within 30 days of the final rule's publication...
You may also be interested in...
Ingrown Toenail Treatment Use With Retainer Ring System Proposed By FDA
Sodium sulfide 1% gel is safe and effective for OTC treatment of ingrown toenail pain only when used with a retainer ring system to keep the product at the area of application, FDA says in a 1proposed rule published in the Federal Register Oct. 4
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.